Cargando…
Targeting SOD1 induces synthetic lethal killing in BLM- and CHEK2-deficient colorectal cancer cells
Cancer is a major cause of death throughout the world, and there is a large need for better and more personalized approaches to combat the disease. Over the past decade, synthetic lethal approaches have been developed that are designed to exploit the aberrant molecular origins (i.e. defective genes)...
Autores principales: | Sajesh, Babu V., McManus, Kirk J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695034/ https://www.ncbi.nlm.nih.gov/pubmed/26318585 |
Ejemplares similares
-
Synthetic Lethal Targeting of Superoxide Dismutase 1 Selectively Kills RAD54B-Deficient Colorectal Cancer Cells
por: Sajesh, Babu V., et al.
Publicado: (2013) -
The synthetic lethal killing of RAD54B-deficient colorectal cancer cells by PARP1 inhibition is enhanced with SOD1 inhibition
por: McAndrew, Erin N., et al.
Publicado: (2016) -
Synthetic Genetic Targeting of Genome Instability in Cancer
por: Sajesh, Babu V., et al.
Publicado: (2013) -
An Evolutionarily Conserved Synthetic Lethal Interaction Network Identifies FEN1 as a Broad-Spectrum Target for Anticancer Therapeutic Development
por: van Pel, Derek M., et al.
Publicado: (2013) -
Correction: An Evolutionarily Conserved Synthetic Lethal Interaction Network Identifies FEN1 as a Broad-Spectrum Target for Anticancer Therapeutic Development
por: van Pel, Derek M., et al.
Publicado: (2013)